Snyder Mark Howard

CIK 00019028661 companySAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001902866

Recent Transactions

50 trades

Tax Payment
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-02-23$70.64/sh−3,782→ 47,610 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Restricted Stock Units
2026-02-23−7,011→ 14,022 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-02-23+7,011→ 51,392 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-02-20+5,332→ 47,257 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Restricted Stock Units
2026-02-20−5,332→ 15,995 total
Tax Payment
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-02-20$70.98/sh−2,876→ 44,381 total
Tax Payment
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-02-16$79.44/sh−2,587→ 36,390 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Performance Stock Units
2026-02-16−12,016→ 0 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Restricted Stock Units
2026-02-16−4,796→ 4,796 total
Tax Payment
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-02-16$79.44/sh−6,481→ 41,925 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-02-16+12,016→ 48,406 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-02-16+4,796→ 38,977 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Option to Purchase Common Stock
2026-02-09+18,730→ 18,730 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Performance Stock Units
2026-02-09+29,502→ 29,502 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Performance Stock Units
2026-02-09+7,808→ 45,127 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Performance Stock Units
2026-02-09+4,651→ 12,016 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Restricted Stock Units
2026-02-09+17,396→ 17,396 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-01-03+7,611→ 38,424 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Restricted Stock Units
2026-01-03−7,611→ 0 total
Tax Payment
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-01-03$70.31/sh−4,243→ 34,181 total
Tax Payment
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-06-12$54.54/sh−2,711→ 30,813 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-06-12+5,035→ 33,524 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Restricted Stock Units
2025-06-12−5,035→ 15,102 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-02-23+7,012→ 32,264 total
Tax Payment
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-02-23$57.75/sh−3,775→ 28,489 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Restricted Stock Units
2025-02-23−7,012→ 21,033 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Restricted Stock Units
2025-02-20+21,327→ 21,327 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Option to Purchase Common Stock
2025-02-20+22,603→ 22,603 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-02-16+4,796→ 27,834 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Performance Stock Units
2025-02-16−17,409→ 0 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Restricted Stock Units
2025-02-16−4,796→ 9,592 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-02-16+17,409→ 32,411 total
Tax Payment
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-02-16$58.29/sh−9,373→ 23,038 total
Tax Payment
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-02-16$58.29/sh−2,582→ 25,252 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Performance Stock Units
2025-02-12+6,050→ 17,409 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Performance Stock Units
2025-02-12+4,698→ 7,365 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Performance Stock Unit
2025-02-12+7,269→ 7,269 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Performance Stock Units
2025-02-12+30,050→ 30,050 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Restricted Stock Units
2025-01-03−7,611→ 7,611 total
Tax Payment
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-01-03$47.74/sh−4,289→ 15,002 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-01-03+7,611→ 19,291 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Restricted Stock Units
2024-06-12+20,137→ 20,137 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Option to Purchase Common Stock
2024-02-23+29,064→ 29,064 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Restricted Stock Units
2024-02-23+28,045→ 28,045 total
Tax Payment
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2024-02-16$36.10/sh−2,577→ 11,680 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Restricted Stock Units
2024-02-16−4,796→ 14,388 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2024-02-16+4,796→ 14,257 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Restricted Stock Units
2024-01-03−7,611→ 15,222 total
Tax Payment
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2024-01-03$35.78/sh−2,957→ 9,461 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2024-01-03+7,611→ 12,418 total

Companies

HALOZYME THERAPEUTICS, INC.
SVP, CHIEF LEGAL OFFICER
$HALO

Recent Filings

Address

C/O HALOZYME THERAPEUTICS, INC. 12390 EL CAMINO REAL

SAN DIEGO, CA, 92130

View on SEC.gov